DJIA 16,790.19 13.76 0.08%
NASDAQ 4,748.36 -32.90 -0.69%
S&P 500 1,979.92 -7.13 -0.36%
market minute promo

company name or ticker

Will it trade high? Cannabis biotech Zynerba Pharmaceuticals sets terms for $42 million IPO

Midyear Report Card: Grading My Biotech Predictions for 2015

One Foolish investor shines a bright light on his biotech stocks predictions for this year.

Here's Why Marijuana Probably Won't Be Legalized by the Federal Government Before 2020

If you think marijuana legalization is around the corner, then this will probably change your tune.

3 Marijuana Stocks to Watch

There are lots of marijuana stocks to avoid, but these 3 merit investors' attention.

This Is a Big Win for Marijuana and Researchers

The Department of Health and Human Services just made a major change to the drug development process for marijuana-based therapies.

European ADRs Advance as Prospect of Greek Bailout Boosts Investor Confidence

Uncovering the cannabis cure: Zynerba Pharmaceuticals files for a $58 million IPO

European ADRs Ebb as Pharma Stocks Contract

Jim Cramer's Top Takeaways: Domino's, GW Pharmaceuticals, Bed Bath & Beyond

This Week In Pharma: Controversies And Revelations About Synergy And Zogenix

See More Articles...